Today: 9 June 2026
Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis
31 December 2025
1 min read

Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis

NEW YORK, December 30, 2025, 21:26 ET — Market closed.

  • Reddit closed down 0.55% at $233.36 in New York trading
  • An SEC filing showed CTO Christopher Slowe sold 14,000 shares under a Rule 10b5-1 plan
  • Needham reiterated a Buy and a $300 target, citing Reddit’s prominence in AI-generated answers

Reddit, Inc. (RDDT) shares slipped 0.55% on Tuesday to close at $233.36 after a showed its chief technology officer sold shares.

The pullback landed in a holiday-thin stretch of trading, when fresh headlines can move growth stocks more than usual. Investors are also trying to pin down whether Reddit can turn its growing role in AI-powered search and chatbots into steadier advertising and data-licensing revenue.

Needham reiterated a Buy rating and a $300 price target on Monday, pointing to what it described as Reddit’s “AI citation dominance” — how often its communities show up as sources in AI-generated answers.

Reddit swung between $229.08 and $236.93, with about 2.48 million shares changing hands. The stock was last quoted at $232.65 in extended trading, according to .

Christopher Slowe sold 14,000 shares on Dec. 22 for about $3.27 million at weighted-average prices ranging from $231.49 to $240.10, the filing showed. He also exercised options and ended with 171,694 shares held directly after the transactions.

The trades were executed under a Rule 10b5-1 plan — a pre-set trading schedule that lets insiders buy or sell stock at set times rather than making discretionary trades.

Needham analyst Laura Martin said Reddit is “a key source of information for large language models,” the AI systems behind chatbots and search assistants, according to InvestorsObserver.

A that tracked citations across ChatGPT, Google’s AI Mode and Perplexity found Reddit among the most-cited domains, while also showing that citation patterns can swing sharply over short periods.

U.S. stocks ended modestly lower, with the S&P 500 down 0.14% and the Nasdaq off 0.23% as traders digested Fed minutes and positioned into year-end. (See Reuters market wrap .)

Minutes from the Federal Reserve’s Dec. 9-10 meeting showed officials were divided after a quarter-point cut that lowered the benchmark rate to a 3.5%–3.75% range.

For advertisers, Reddit competes for budgets with larger social platforms such as Meta Platforms and Snap, while its AI visibility is increasingly compared with content-heavy sites like Wikipedia and YouTube.

Before the next session on Wednesday — the final trading day of 2025 — traders will watch whether thin liquidity keeps amplifying moves in momentum names like Reddit. Tuesday’s low near $229 is a level short-term traders are likely to monitor.

The next macro tests come in early January, with December jobs and consumer-price data due Jan. 9 and Jan. 13 and the Fed’s next meeting scheduled for Jan. 27-28, Reuters reported in its minutes story . Investing.com lists Feb. 18, 2026 as Reddit’s next earnings date , putting the focus on ad demand and any monetization tied to AI-driven discovery.

Stock Market Today

  • Nurix Therapeutics Surges 6.8% on Roche Collaboration Deal
    June 9, 2026, 8:02 AM EDT. Shares of Nurix Therapeutics (NRIX) jumped 6.8% to $15.64 following a transformative collaboration with Roche. The agreement includes a $700 million upfront payment and potential milestone payments up to $2.3 billion for Nurix's investigational BTK degrader, bexobrutideg. This deal broadens development beyond chronic lymphocytic leukemia to other diseases like multiple sclerosis, boosting investor confidence. Despite expected quarterly losses and revenue decline, the partnership mitigates execution risk and enhances long-term growth prospects. Analysts note the stock's price increase lacks accompanying earnings estimate revisions, urging cautious monitoring. NRIX holds a Zacks Rank #3 (Hold). In the same sector, NovoCure (NVCR) fell 1.8%, with mixed earnings outlook.

Latest articles

CCSC stock pops ahead of the bell as Nasdaq deadline looms

CCSC stock pops ahead of the bell as Nasdaq deadline looms

9 June 2026
CCSC Technology International Holdings shares soared 315% to $1.99 in U.S. premarket trading, putting the microcap near Nasdaq’s $1 minimum bid price just days before a June 15 compliance deadline, but only a regular-session closing price above $1 counts toward regaining listing compliance.
Core AI Stock Jumps 474% Premarket, Market Watches Filing

Core AI Stock Jumps 474% Premarket, Market Watches Filing

9 June 2026
Core AI Holdings shares soared 474% to $4.71 in premarket trading on heavy volume despite no new company news, as speculative AI stocks rallied with Nasdaq futures; however, the company faces a going-concern warning, a $32 million deficit, and just $1.93 million in year-end cash, raising major funding and execution risks.
Plug Power Stock Returns to $3 as Traders Zero In on Key Level

Plug Power Stock Returns to $3 as Traders Zero In on Key Level

9 June 2026
Plug Power stock hovered near $3.19 premarket after a 22% drop since June 2, as investors focus on cash and dilution risks ahead of the June 11 shareholder meeting, a recent $39.2 million tax-credit cash raise, and a new Form 144 notice for a proposed 50,000-share sale, keeping the company’s liquidity plan under scrutiny.
Tesla’s China Deal Buys Time. Robotaxi Bets Still in Focus

Tesla’s China Deal Buys Time. Robotaxi Bets Still in Focus

9 June 2026
Tesla surged 4.63% to $408.97 after May China retail sales jumped 22.53% year-on-year to 47,281 vehicles, ending a two-month decline, giving investors a concrete reason to revisit the stock ahead of Tuesday’s open, but risks remain as year-to-date sales are still down and the robotaxi fleet is small.
Micron Shares Edge Higher Again, But AI Memory Push Still Has a Snag

Micron Shares Edge Higher Again, But AI Memory Push Still Has a Snag

9 June 2026
Micron Technology jumped 3.77% premarket to $985.04 as investors returned to AI memory stocks, with analyst target hikes and strong demand for high-bandwidth memory driving gains; upcoming June 24 earnings will test whether Micron’s shift to stable, AI-driven revenue can justify its new valuation.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop